Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 19 10:11AM ET
2.05
Dollar change
+0.77
Percentage change
59.77
%
Index- P/E- EPS (ttm)-14.42 Insider Own10.99% Shs Outstand2.84M Perf Week50.37%
Market Cap5.81M Forward P/E- EPS next Y-2.27 Insider Trans0.00% Shs Float2.53M Perf Month258.71%
Income-16.89M PEG- EPS next Q-1.53 Inst Own0.07% Short Float1.45% Perf Quarter-49.38%
Sales0.00M P/S- EPS this Y56.21% Inst Trans-8.75% Short Ratio0.01 Perf Half Y-31.51%
Book/sh-1.04 P/B- EPS next Y60.04% ROA-156.21% Short Interest0.04M Perf Year-78.24%
Cash/sh0.66 P/C3.11 EPS next 5Y- ROE-241.52% 52W Range0.46 - 10.00 Perf YTD-36.11%
Dividend Est.- P/FCF- EPS past 5Y-20.69% ROI- 52W High-79.55% Beta1.24
Dividend TTM- Quick Ratio0.72 Sales past 5Y0.00% Gross Margin- 52W Low344.28% ATR (14)0.39
Dividend Ex-Date- Current Ratio0.72 EPS Y/Y TTM6.35% Oper. Margin0.00% RSI (14)67.92 Volatility28.30% 28.27%
Employees7 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price3.00
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q-111.83% Payout- Rel Volume35.74 Prev Close1.28
Sales Surprise- EPS Surprise- Sales Q/Q- EarningsMay 13 AMC Avg Volume5.14M Price2.05
SMA20126.77% SMA50103.02% SMA200-43.92% Trades Volume27,541,266 Change59.77%
Jul-10-24 12:08PM
11:45AM
11:29AM
07:30AM
Jul-08-24 12:36PM
11:56AM Loading…
11:56AM
07:30AM
Jun-18-24 07:37AM
May-29-24 07:30AM
May-15-24 01:55PM
08:36AM
08:20AM
08:14AM
08:00AM
07:29AM
10:53PM Loading…
May-13-24 10:53PM
04:10PM
Apr-30-24 07:30AM
Apr-24-24 02:52PM
Mar-26-24 07:30AM
Feb-27-24 07:31AM
07:30AM
Feb-07-24 07:30AM
Dec-29-23 07:30AM
Nov-17-23 07:10AM
07:00AM
Nov-15-23 04:15PM
Oct-31-23 08:58AM
Oct-12-23 08:02AM
Oct-02-23 08:58AM
08:58AM Loading…
Sep-27-23 08:58AM
Sep-26-23 08:58AM
Sep-22-23 11:27AM
Sep-21-23 10:00AM
Sep-18-23 07:58AM
Sep-05-23 09:00AM
Aug-28-23 08:58AM
Aug-14-23 09:00AM
Aug-10-23 08:58AM
Jul-24-23 07:00AM
Jul-13-23 08:58AM
Jun-21-23 08:00AM
Jun-20-23 04:10PM
Jun-13-23 08:58AM
May-12-23 04:08PM
May-10-23 07:15AM
May-09-23 07:15AM
May-04-23 08:58AM
May-02-23 03:30PM
Apr-27-23 08:58AM
Apr-05-23 08:58AM
Mar-28-23 08:58AM
Mar-22-23 08:58AM
Feb-13-23 08:58AM
Jan-31-23 08:58AM
Jan-18-23 09:00AM
Jan-10-23 09:00AM
Jan-04-23 09:00AM
Dec-14-22 09:00AM
Nov-09-22 09:00AM
Oct-13-22 06:29AM
Aug-24-22 09:00AM
Aug-15-22 09:00AM
Jul-22-22 11:32AM
Jul-05-22 09:00AM
Jul-01-22 04:04PM
06:33AM
Jun-30-22 06:44AM
04:00AM
Jun-29-22 04:06PM
11:30AM
09:32AM
Jun-28-22 07:08PM
05:01PM
04:37PM
11:14AM
Jun-27-22 12:13PM
09:00AM
Jun-24-22 12:25PM
Jun-23-22 04:34PM
04:00AM
May-19-22 09:00AM
May-16-22 09:00AM
May-06-22 06:12AM
May-05-22 09:00AM
Apr-26-22 09:00AM
Mar-31-22 09:00AM
Mar-22-22 09:00AM
04:00AM
Mar-15-22 01:45PM
10:06AM
09:00AM
Feb-15-22 09:00AM
Feb-10-22 09:00AM
Jan-21-22 11:00AM
Jan-18-22 09:00AM
Jan-04-22 09:20AM
Dec-28-21 08:00AM
Dec-20-21 08:00AM
Dec-08-21 08:00AM
Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray. The company was founded by Anthony P. Mack and Jeffrey A. Gudin in 2016 and and is headquartered in Berwyn, PA.